Catalyst Pharma Group, Inc.
790 E Colorado Boulevard
Suite 720
Pasadena
California
91101
United States
Tel: 626-568-8645
Fax: 626-568-8667
Website: http://www.catalystpharm.com/
Email: info@catalystpharm.com
6 articles about Catalyst Pharma Group, Inc.
-
Catalyst Pharmaceuticals Files Federal Lawsuit Against U.S. Food and Drug Administration
6/12/2019
Complaint Cites Multiple Violations of Food, Drug, and Cosmetic Act
-
Catalyst Pharmaceuticals to Hold Fourth Quarter Financial Results and Corporate Update Conference Call and Webcast on Tuesday, March 19th, 2019
3/11/2019
Catalyst management will host an investment-community conference call at 8:30 a.m. ET on Tuesday, March 19, 2019 to discuss the financial results and to provide a corporate update.
-
Catalyst Pharmaceuticals to Participate in Two Upcoming September and October 2018 Investor Conferences
9/20/2018
Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease on September 25-27 in New York City
-
Catalyst Pharmaceuticals to Hold Second Quarter Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 8th, 2018
8/1/2018
Catalyst Pharmaceuticals, Inc. announced that it will release second quarter 2018 financial results after market close on Tuesday, August 7, 2018.
-
Catalyst Pharmaceuticals Appoints Daniel J. Brennan as Chief Commercial Officer
6/13/2018
Catalyst Pharmaceuticals, Inc. announced the appointment of Daniel J. Brennan as Chief Commercial Officer.
-
Catalyst CRO Joins Spacelabs Medical In Strategic Partnership
8/17/2004